Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Janssen

Janssen
1953 FOUNDED
M&A STATUS
95K-100K EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
8 INVESTMENTS
Description

Manufacturer and developer of pharmaceutical products. The company's activities include research, development, manufacturing and marketing of pharmaceutical products for wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer, enabling customers to improve their health condition.

Website
Formerly Known As
N.V. Laboratoria Pharmaceutica, Laboratoria Pharmaceutica
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Primary Office
  • 1000 U.S. Route 202 South
  • PO Box 200
  • Raritan, NJ 08869
  • United States

+1 (908) 000-0000

Janssen Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Janssen‘s full profile, request access.

Request full access to PitchBook

Janssen Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Prometheus Laboratories Formerly VC-backed San Diego, CA 000 000000&0
0000000000 Private Debt Financed Aachen, Germany 0000 000000000
00000000 000000000 Formerly VC-backed Marlborough, MA 0000 000000&0
00000000 Corporation Valby, Denmark 0000
00000 000000000000 Formerly VC-backed Bridgewater, NJ 0000 00000 000000&0
To view this company’s complete list of competitors, request access »

Janssen Investments (8)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 (00000000 07-Dec-2019 000000000 00000 00 00000 Buildings and Property
000000000 01-Jan-2018 000000000 Other Healthcare Technology Systems
0000000 0000000 01-Nov-2017 00000 Decision/Risk Analysis
00000000 000000000 06-Jun-2016 00000 00000 Biotechnology
HelixNano 09-Dec-2014 Accelerator/Incubator Biotechnology
To view this company’s complete investment and acquisition history, request access »

Janssen Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 0000000000 01-Jul-2014 000 000.00 Completed
  • 4 buyers
Minerva Neurosciences Early Stage VC Completed
  • 4 buyers
To view this company’s complete exits history, request access »

Janssen Executive Team (2)

Name Title Board
Seat
Contact
Info
Stef Heylen MD Chief Operating Officer
Patrick Verheyen Head, Business Development